IGC Pharma Inc (AMEX: IGC) closed the day trading at $0.57 down -7.26% from the previous closing price of $0.62. In other words, the price has decreased by -$0.0450 from its previous closing price. On the day, 802745 shares were traded.
Ratios:
For a better understanding of IGC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGC now has a Market Capitalization of 37.99M and an Enterprise Value of 36.99M. For the stock, the TTM Price-to-Sale (P/S) ratio is 31.36 while its Price-to-Book (P/B) ratio in mrq is 4.05. Its current Enterprise Value per Revenue stands at 30.42 whereas that against EBITDA is -3.35.
Stock Price History:
Over the past 52 weeks, IGC has reached a high of $0.91, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 0.3634, while the 200-Day Moving Average is calculated to be 0.3354.
Shares Statistics:
Over the past 3-months, IGC traded about 758.32K shares per day on average, while over the past 10 days, IGC traded about 2.01M shares per day. A total of 66.54M shares are outstanding, with a floating share count of 59.23M. Insiders hold about 10.98% of the company’s shares, while institutions hold 3.71% stake in the company. Shares short for IGC as of Mar 28, 2024 were 938.8k with a Short Ratio of 1.12, compared to 910.73k on Feb 29, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.42% and a Short% of Float of 1.50%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.22 and -$0.22 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is -$0.16, with 1 analysts recommending between -$0.16 and -$0.16.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $1.4M in the next fiscal year. The high estimate is $1.4M and the low estimate is $1.4M. The average revenue growth estimate for next year is up 12.90% from the average revenue estimate for this year.
